Chronic pain moving from symptom control to mechanism-based treatment

Current Medical Research and Opinion

Volumn 27, Issue 10, 2011, Pages 2079-2080

  Pergolizzi, Joseph ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Naples Anesthesia and Pain Associates   (United States)

Author keywords

opioid receptor system; Fixed drug combinations; Loose drug combinations; Mechanism orientated treatment; Monoaminergic system; Multiple pain mechanisms

Indexed keywords

ANALGESIC AGENT; CODEINE; GABAPENTIN; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NORADRENALIN; OXYCODONE; PARACETAMOL; PREGABALIN;

ALLODYNIA; CHRONIC PAIN; CONFERENCE PAPER; DRUG POTENTIATION; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERALGESIA; LOW BACK PAIN; LOW DRUG DOSE; MONOAMINERGIC SYSTEM; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; OSTEOARTHRITIS; POSTHERPETIC NEURALGIA; PSYCHOSOMATIC DISORDER; SIGNAL TRANSDUCTION; VISCERAL PAIN;

CHRONIC PAIN; CONGRESSES AS TOPIC; HUMANS; PAIN MANAGEMENT; PAIN MEASUREMENT; VISCERAL PAIN;

EID: 80053006002     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.619446     Document Type: Conference Paper

References (21)

1. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-9
2. Varrassi G, Mü ller-Schwefe G, Pergolizzi J, et al. Pharmacological treatment of chronic pain - the need for CHANGE. Curr Med Res Opin 2010;26:1055-69
3. Mü ller-Schwefe G, Jaksch W, Morlion B, et al. Make a CHANGE: optimising communication and pain management decisions. Curr Med Res Opin 2010; 27:481-8
4. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-64
5. Woolf CJ, Max MB. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology 2001;95:241-9 (Pubitemid 32623017)
6. Raffa RB, Pergolizzi JV, Tallarida RJ. The determination and application of fixed-dose analgesic combinations for treating multimodal pain. J Pain 2010; 11:701-9
7. Miller KE, Miller MM, Jolley MR. Challenges in pain management at the end of life. Am Fam Physician 2001;64:1227-34 (Pubitemid 32947510)
8. Weinstein SM. Physical examination. In: Ashburn MA, Rice LJ, eds. The Management of Pain. New York: Churchill Livingstone, 1998
9. Lipman AG. Pharmacological approaches to pain management: nontraditional analgesics and analgesic adjuvants. In: Ashburn MA, Rice LJ, eds. The Management of Pain. New York: Churchill Livingstone, 1998
10. Woolf CJ. Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci 2004;74:2605-10 (Pubitemid 38369357)
11. Freynhagen R, Baron R, Gockel U, et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006;22:1911-20 (Pubitemid 44663395)
12. Ashburn M, Staats P. Management of chronic pain. Lancet 1999;353:1865-9 (Pubitemid 29251030)
13. Ballantyne JC, Mao JM. Opioid therapy for chronic pain. N Engl J Med 2003;349:1943-53 (Pubitemid 37409712)
14. Besson M, Piguet V, Dayer P, et al. New approaches to the pharmacotherapy of neuropathic pain. Expert Rev Clin Pharmacol 2008;1:683-93
15. Raffa RB. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther 2001;26:257-64 (Pubitemid 34205775)
16. Raffa RB. Pharmacological aspects of successful long-term analgesia. Clin Rheumatol 2006;25:S9-S15
17. Hanna M, O'Brien C, Wilson MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008;12:804-13
18. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:2650-1 (Pubitemid 41007857)
19. Zin CS, Nissen LM, O'Callaghan JP, et al. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. J Pain 2010;11:462-71
20. Clemens KE, Mikus G. Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain. Expert Opin Pharmacother 2010;11:297-310
21. Davis MP. What is new in neuropathic pain? Support Care Cancer 2007; 15:363-72 (Pubitemid 46697011)